✦ LIBER ✦

Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated with second-line cyclophosphamide-based metronomic chemotherapy

✍ Scribed by Thomas Nelius; Tobias Klatte; Werner de Riese; Allan Haynes; Stephanie Filleur

Book ID: 107576846
Publisher: Springer US
Year: 2009
Tongue: English
Weight: 201 KB
Volume: 27
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-009-9218-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First- and second-line chemotherapy with

First- and second-line chemotherapy with docetaxel or mitoxantrone in patients with hormone-refractory prostate cancer : Does sequence matter?

✍ Jorg Michels; Trina Montemurro; Nevin Murray; Christian Kollmannsberger; Kim Ngu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

Response to docetaxel/carboplatin-based

Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer

✍ Mari Nakabayashi; Oliver Sartor; Susanna Jacobus; Meredith M. Regan; David McKea 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Adrenal androgen levels as predictors of

Adrenal androgen levels as predictors of outcome in castration-resistant prostate cancer patients treated with combined androgen blockade using flutamide as a second-line anti-androgen

✍ Kazutaka Narimoto; Atsushi Mizokami; Kouji Izumi; Shinya Mihara; Kiyoshi Sawada; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB